Nicox S.A. announced the U.S. launch of a point-of-care diagnostic test (AdenoPlus) that aids in the differential diagnosis of acute conjunctivitis.
Re-Vana Therapeutics raises $11.9 million in Series A financing for development of ophthalmic therapeutics
Harrow and iOR Partners expand national product supply agreement
OWL, WIO to co-host networking reception during Hawaiian Eye
